{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:30:09Z","timestamp":1787671809147,"version":"build-2736575974"},"reference-count":94,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82500267"],"award-info":[{"award-number":["82500267"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Protein palmitoylation has emerged as a central post-translational mechanism governing protein localization, stability, and signal transduction. In hematological malignancies, this dynamic modification lies at the intersection of lipid metabolic reprogramming, tumor\u2013immune interactions, and therapeutic resistance. Here, we review how dysregulated palmitoyltransferases and depalmitoylases modify metabolic enzymes, lipid transporters, lipid-droplet proteins, oncogenic signaling components, and immune-regulatory molecules, thereby creating self-reinforcing circuits that sustain tumor growth and treatment failure. We further discuss the contribution of macrophage and myeloid-cell lipid metabolism, the potential roles of palmitoylation in non-malignant cells of the tumor microenvironment, and the underexplored relevance of palmitoylation to multiple myeloma. Particular attention is given to crosstalk with phosphorylation and ubiquitination, as well as to the distinction between direct evidence from hematological malignancies and cross-tumor mechanistic inferences. Finally, we evaluate emerging therapeutic strategies, including selective enzyme inhibitors, proteolysis-targeting chimeras, metabolic modulation, and immunotherapy combinations. This evidence-calibrated framework highlights both the translational potential of targeting palmitoylation and the need for cell-type-resolved validation in blood cancers.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1942607","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:53:30Z","timestamp":1787669610000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Protein palmitoylation in hematological malignancies: mechanistic links to lipid metabolic reprogramming and therapy resistance"],"prefix":"10.3389","volume":"17","author":[{"given":"Qian","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Hematology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangang","family":"Mei","sequence":"additional","affiliation":[{"name":"Department of Hematology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Hematology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Pu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Renji Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1652741","article-title":"Protein palmitoylation: an emerging regulator of inflammatory signaling and diseases","volume":"16","author":"Chen","year":"2025","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189509","article-title":"Targeting palmitoylation: a novel frontier in cancer biology and immunotherapy","volume":"1881","author":"Yang","year":"2026","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"8200","DOI":"10.1038\/ncomms9200","article-title":"Activity-regulated trafficking of the palmitoyl-acyl transferase DHHC5","volume":"6","author":"Brigidi","year":"2015","journal-title":"Nat Commun"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2015.6375","article-title":"Selenoprotein K and protein palmitoylation","volume":"23","author":"Fredericks","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.987499","article-title":"Reprogramming lipid metabolism as potential strategy for hematological Malignancy therapy","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1531928","article-title":"Lipid metabolism in multiple myeloma: pathogenesis, therapeutic opportunities, and future directions","volume":"15","author":"Wang","year":"2025","journal-title":"Front Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1038\/s41598-025-87684-3","article-title":"Unveiling the omics tapestry of B-acute lymphoblastic leukemia: bridging genomics, metabolomics, and immunomics","volume":"15","author":"Le","year":"2025","journal-title":"Sci Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-23-2266","article-title":"PRMT1 sustains de novo fatty acid synthesis by methylating PHGDH to drive chemoresistance in triple-negative breast cancer","volume":"84","author":"Yamamoto","year":"2024","journal-title":"Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.1038\/s41467-023-42170-0","article-title":"Palmitoylation-driven PHF2 ubiquitination remodels lipid metabolism through the SREBP1c axis in hepatocellular carcinoma","volume":"14","author":"Jeong","year":"2023","journal-title":"Nat Commun"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1038\/s41467-020-18565-8","article-title":"CD36 facilitates fatty acid uptake by dynamic palmitoylation-regulated endocytosis","volume":"11","author":"Hao","year":"2020","journal-title":"Nat Commun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1122895","article-title":"Post-translational palmitoylation of metabolic proteins","volume":"14","author":"Dennis","year":"2023","journal-title":"Front Physiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003530","article-title":"Genetic disruption of N-RasG12D palmitoylation perturbs hematopoiesis and prevents myeloid transformation in mice","volume":"135","author":"Zambetti","year":"2020","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-019-0375-6","article-title":"Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours","volume":"3","author":"Yao","year":"2019","journal-title":"Nat BioMed Eng"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-018-0124-5","article-title":"Palmitoylation stabilizes PD-L1 to promote breast tumor growth","volume":"29","author":"Yang","year":"2019","journal-title":"Cell Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022019056","article-title":"The palmitoyltransferase ZDHHC21 regulates oxidative phosphorylation to induce differentiation block and stemness in AML","volume":"142","author":"Shao","year":"2023","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.1038\/s41467-025-58552-5","article-title":"Palmitoylation prevents B7-H4 lysosomal degradation sustaining tumor immune evasion","volume":"16","author":"Yan","year":"2025","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellin.2025.100248","article-title":"Targeting PD-1 post-translational modifications for improving cancer immunotherapy","volume":"4","author":"Shi","year":"2025","journal-title":"Cell Insight"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2025.101264","article-title":"The shadow of cancer therapeutic resistance: unveiling the role of S-palmitoylation","volume":"82","author":"Yang","year":"2025","journal-title":"Drug Resist Update"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.34133\/research.0708","article-title":"Dual regulation of Sprouty 4 palmitoylation by ZDHHC7 and palmitoyl-protein thioesterase 1: a potential therapeutic strategy for cisplatin-resistant osteosarcoma","volume":"8","author":"Huang","year":"2025","journal-title":"Res (Wash D C)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30122","article-title":"Protein palmitoylation and its pathophysiological relevance","volume":"236","author":"Jin","year":"2021","journal-title":"J Cell Physiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.600368","article-title":"Protein palmitoylation in leukocyte signaling and function","volume":"8","author":"Yang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1547636","article-title":"Advances in targeting protein S-palmitoylation in tumor immunity and therapy","volume":"15","author":"Han","year":"2025","journal-title":"Front Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1237964","article-title":"A cyclic peptide-based PROTAC induces intracellular degradation of palmitoyltransferase and potently decreases PD-L1 expression in human cervical cancer cells","volume":"14","author":"Shi","year":"2023","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0299665","article-title":"Targeted degradation of zDHHC-PATs decreases substrate S-palmitoylation","volume":"19","author":"Bai","year":"2024","journal-title":"PloS One"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.3.2191","article-title":"Lipid-dependent targeting of G proteins into rafts","volume":"275","author":"Moffett","year":"2000","journal-title":"J Biol Chem"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-2489-0_16","article-title":"Removable backbone modification (RBM) strategy for the chemical synthesis of hydrophobic peptides\/proteins","volume":"2530","author":"Huang","year":"2022","journal-title":"Methods Mol Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.64046","article-title":"Lipid-induced S-palmitoylation as a vital regulator of cell signaling and disease development","volume":"17","author":"Qu","year":"2021","journal-title":"Int J Biol Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1186\/s12967-023-04611-8","article-title":"Palmitoylation landscapes across human cancers reveal a role of palmitoylation in tumorigenesis","volume":"21","author":"Kong","year":"2023","journal-title":"J Transl Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpc.2023.107124","article-title":"Palmitoylation modifies transmembrane adaptor protein PAG for ordered lipid environment: a molecular dynamics simulation study","volume":"304","author":"Saija","year":"2024","journal-title":"Biophys Chem"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-213876","article-title":"Palmitoylation of oncogenic NRAS is essential for leukemogenesis","volume":"115","author":"Cuiffo","year":"2010","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13045-015-0226-1","article-title":"Roles of palmitoylation and the KIKK membrane-targeting motif in leukemogenesis by oncogenic KRAS4A","volume":"8","author":"Zhao","year":"2015","journal-title":"J Hematol Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-024-01371-z","article-title":"Palmitoyltransferase ZDHHC3 is essential for the oncogenic activity of PML\/RARalpha in acute promyelocytic leukemia","volume":"46","author":"Shao","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021011582","article-title":"Depalmitoylation rewires FLT3-ITD signaling and exacerbates leukemia progression","volume":"138","author":"Lv","year":"2021","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12964-025-02579-0","article-title":"Polydatin upregulates ZDHHC19 to promote apoptosis of acute myeloid leukemia cells via mediating BID palmitoylation","volume":"24","author":"Zhang","year":"2025","journal-title":"Cell Commun Signal"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.145876","article-title":"Palmitoylation by ZDHHC family members regulate B-cell lymphoma growth","volume":"320","author":"Liu","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-02130-5","article-title":"Targeting ZDHHC21\/FASN axis for the treatment of diffuse large B-cell lymphoma","volume":"38","author":"Liu","year":"2024","journal-title":"Leukemia"},{"key":"B37","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41419-020-03311-1","article-title":"GNA13 regulates BCL2 expression and the sensitivity of GCB-DLBCL cells to BCL2 inhibitors in a palmitoylation-dependent manner","volume":"12","author":"Xia","year":"2021","journal-title":"Cell Death Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113320","article-title":"Palmitic acid inhibits macrophage-mediated chemotherapy resistance in multiple myeloma via ALOX12 signaling","volume":"143","author":"Dong","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s40164-024-00576-6","article-title":"Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma","volume":"13","author":"Pu","year":"2024","journal-title":"Exp Hematol Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.02.973","article-title":"Hair growth cycle is arrested in SCD1 deficiency by impaired Wnt3a-palmitoleoylation and retrieved by the artificial lipid barrier","volume":"137","author":"Stoffel","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101592","article-title":"A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML","volume":"5","author":"Guo","year":"2024","journal-title":"Cell Rep Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","article-title":"CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability","volume":"33","author":"Ma","year":"2021","journal-title":"Cell Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-024-01085-w","article-title":"S-acylation of ATGL is required for lipid droplet homoeostasis in hepatocytes","volume":"6","author":"Zheng","year":"2024","journal-title":"Nat Metab"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202502060","article-title":"Synergistic combination of tamoxifen-tetraphenylethylene co-assembled micelles and orlistat-induced lipid droplet inhibition to overcome tamoxifen resistance","volume":"14","author":"Park","year":"2025","journal-title":"Adv Healthc Mater"},{"key":"B45","doi-asserted-by":"publisher","first-page":"5371","DOI":"10.1038\/s41467-022-33138-7","article-title":"Fatty acid metabolism in aggressive B-cell lymphoma is inhibited by tetraspanin CD37","volume":"13","author":"Peeters","year":"2022","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2025.288472","article-title":"IDH1-mutated B-cell acute lymphoblastic leukemia characterized by oncogenic reprogramming of lipid metabolism","volume":"111","author":"Qian","year":"2026","journal-title":"Haematologica"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1172\/jci171104","article-title":"Mechanisms for regulation of RAS palmitoylation and plasma membrane trafficking in hematopoietic Malignancies","volume":"133","author":"Yu","year":"2023","journal-title":"J Clin Invest"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-331857","article-title":"High-fat diet-induced AKT-palmitoylation in hepatocellular carcinoma: a breakthrough mechanistic investigation","volume":"73","author":"Keating","year":"2024","journal-title":"Gut"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-022-0942-1","article-title":"ACSL5, a prognostic factor in acute myeloid leukemia, modulates the activity of Wnt\/beta-catenin signaling by palmitoylation modification","volume":"17","author":"Ye","year":"2023","journal-title":"Front Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2799-2","article-title":"A STAT3 palmitoylation cycle promotes T(H)17 differentiation and colitis","volume":"586","author":"Zhang","year":"2020","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvad082","article-title":"Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing peroxisome proliferator-activated receptor alpha and fundamentally changing lipid metabolism","volume":"119","author":"Cao","year":"2023","journal-title":"Cardiovasc Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s11658-025-00776-w","article-title":"Palmitoylation: an emerging therapeutic target bridging physiology and disease","volume":"30","author":"Li","year":"2025","journal-title":"Cell Mol Biol Lett"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.70544","article-title":"ZDHHC22-mediated mTOR palmitoylation restrains breast cancer growth and endocrine therapy resistance","volume":"18","author":"Huang","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216619","article-title":"AMPKalpha1-mediated ZDHHC8 phosphorylation promotes the palmitoylation of SLC7A11 to facilitate ferroptosis resistance in glioblastoma","volume":"584","author":"Wang","year":"2024","journal-title":"Cancer Lett"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1300","article-title":"Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation","volume":"13","author":"Shi","year":"2023","journal-title":"Clin Transl Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111194","article-title":"S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K\/AKT pathway","volume":"40","author":"Sun","year":"2022","journal-title":"Cell Rep"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1101\/2024.07.18.604152","article-title":"A selective S-acyltransferase inhibitor suppresses tumor growth","author":"Lee","year":"2024","journal-title":"bioRxiv"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.165688","article-title":"PPT1 inhibition enhances the antitumor activity of anti-PD-1 antibody in melanoma","volume":"7","author":"Sharma","year":"2022","journal-title":"JCI Insight"},{"key":"B59","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12935-022-02508-y","article-title":"High PPT1 expression predicts poor clinical outcome and PPT1 inhibitor DC661 enhances sorafenib sensitivity in hepatocellular carcinoma","volume":"22","author":"Xu","year":"2022","journal-title":"Cancer Cell Int"},{"key":"B60","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11626-023-00755-5","article-title":"Involvement of ZDHHC9 in lung adenocarcinoma: regulation of PD-L1 stability via palmitoylation","volume":"59","author":"Li","year":"2023","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"B61","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1039\/d0cb00157k","article-title":"A peptidic inhibitor for PD-1 palmitoylation targets its expression and functions","volume":"2","author":"Yao","year":"2021","journal-title":"RSC Chem Biol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202500971","article-title":"Dysfunctional Decidual CD4(+)T Cells Induce Recurrent Pregnancy Loss via Palmitoylation-Dependent Tim-3 Lysosomal Sorting and Degradation","volume":"12","author":"Cui","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024487","article-title":"Epigenetic agents plus anti-PD-1 reprogram the tumor microenvironment and restore antitumor efficacy in Hodgkin lymphoma","volume":"144","author":"Nie","year":"2024","journal-title":"Blood"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010783","article-title":"JAK3 (A573V) and JAK3 (M511I) mutations in peripheral T-cell lymphoma mediating resistance to anti-PD-1 therapy through the STAT3\/PD-L1 pathway","volume":"13","author":"Lou","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051152","article-title":"PD-1 and LAG-3 checkpoint blockade: potential avenues for therapy in B-cell lymphoma","volume":"10","author":"Tobin","year":"2021","journal-title":"Cells"},{"key":"B66","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s40364-025-00807-w","article-title":"T cells in cancer: mechanistic insights and therapeutic advances","volume":"13","author":"Pu","year":"2025","journal-title":"biomark Res"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/biology14060624","article-title":"The critical role of adipocytes in leukemia","volume":"14","author":"Higos","year":"2025","journal-title":"Biol (Basel)"},{"key":"B68","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s12015-025-11016-1","article-title":"Regulating ferroptosis in leukemic stem cells: from stemness preservation to targeted differentiation strategies","volume":"22","author":"Wang","year":"2026","journal-title":"Stem Cell Rev Rep"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112747","article-title":"Ferroptosis in hematological Malignancies and its potential network with abnormal tumor metabolism","volume":"148","author":"Zhang","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-025-00937-y","article-title":"Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity","volume":"6","author":"Zhou","year":"2025","journal-title":"Nat Cancer"},{"key":"B71","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41467-025-56344-5","article-title":"Palmitoylation-dependent regulation of GPX4 suppresses ferroptosis","volume":"16","author":"Huang","year":"2025","journal-title":"Nat Commun"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3390\/v14030531","article-title":"Identification of SARS-coV-2 spike palmitoylation inhibitors that results in release of attenuated virus with reduced infectivity","volume":"14","author":"Ramadan","year":"2022","journal-title":"Viruses"},{"key":"B73","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41420-025-02629-z","article-title":"Role of S-palmitoylation in digestive system diseases","volume":"11","author":"Li","year":"2025","journal-title":"Cell Death Discov"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2021.07.012","article-title":"Artemisinin inhibits NRas palmitoylation by targeting the protein acyltransferase ZDHHC6","volume":"29","author":"Qiu","year":"2022","journal-title":"Cell Chem Biol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-358960","article-title":"Inhibiting the palmitoylation\/depalmitoylation cycle selectively reduces the growth of hematopoietic cells expressing oncogenic Nras","volume":"119","author":"Xu","year":"2012","journal-title":"Blood"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-021-00785-8","article-title":"ABHD17 regulation of plasma membrane palmitoylation and N-Ras-dependent cancer growth","volume":"17","author":"Remsberg","year":"2021","journal-title":"Nat Chem Biol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1101\/2025.03.20.644389","article-title":"In vivo validation of the palmitoylation cycle as a therapeutic target in NRAS-mutant cancer","author":"Decker","year":"2025","journal-title":"bioRxiv"},{"key":"B78","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.3390\/ijms26125721","article-title":"Downregulation of S6 kinase and hedgehog-gli1 by inhibition of fatty acid synthase in AML with FLT3-ITD mutation","volume":"26","author":"Kebenko","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B79","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41419-024-07182-8","article-title":"Correction: Treating ICB-resistant cancer by inhibiting PD-L1 via DHHC3 degradation induced by cell penetrating peptide-induced chimera conjugates","volume":"15","author":"Shi","year":"2024","journal-title":"Cell Death Dis"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.123022","article-title":"Targeting lipid metabolism via nanomedicine: A prospective strategy for cancer therapy","volume":"317","author":"Huang","year":"2025","journal-title":"Biomaterials"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.3c15686","article-title":"Advances in nanodelivery systems based on metabolism reprogramming strategies for enhanced tumor therapy","volume":"16","author":"Zhang","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1500","article-title":"Synergistic integration of histone deacetylase inhibitors apparently enhances the cytokine-induced killer cell efficiency in multiple myeloma via the NKG2D pathway","volume":"13","author":"Pu","year":"2024","journal-title":"Clin Transl Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70497","article-title":"Balancing CIK cell cancer immunotherapy and PPAR ligands: one potential therapeutic application for CNS Malignancies","volume":"13","author":"Vordermark","year":"2024","journal-title":"Cancer Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.821596","article-title":"Protein palmitoylation modification during viral infection and detection methods of palmitoylated proteins","volume":"12","author":"Li","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-15-3266-5_17","article-title":"Methodology for detecting protein palmitoylation","volume":"1248","author":"Lu","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-4502-4_20","article-title":"Recent overview of protein palmitoylation and profiling methodologies","volume":"2921","author":"Jin","year":"2025","journal-title":"Methods Mol Biol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.101712","article-title":"Protocol to generate a patient derived xenograft model of acquired resistance to immunotherapy in humanized mice","volume":"3","author":"Martinez-Sabadell","year":"2022","journal-title":"STAR Protoc"},{"key":"B88","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1080\/15548627.2024.2403152","article-title":"Divergent effects of acute and chronic PPT1 inhibition in melanoma","volume":"21","author":"Crissey","year":"2025","journal-title":"Autophagy"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60040520","article-title":"State of the art in 3D culture models applied to thyroid cancer","volume":"60","author":"Prete","year":"2024","journal-title":"Med (Kaunas)"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.23.00021","article-title":"Synthetic data generation by artificial intelligence to accelerate research and precision medicine in hematology","volume":"7","author":"D'Amico","year":"2023","journal-title":"JCO Clin Cancer Inform"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1097\/js9.0000000000003381","article-title":"Post-translational modifications at the crossroads of cancer metabolism and immune regulation: therapeutic opportunities and challenges","volume":"112","author":"Liu","year":"2026","journal-title":"Int J Surg"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202300254","article-title":"Simultaneous profiling of palmitoylomics and glycomics with photo\/pH dual-responsive magnetic nanocomposites","volume":"7","author":"Zheng","year":"2023","journal-title":"Small Methods"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.108259","article-title":"Topology-driven discovery of transmembrane protein S-palmitoylation","volume":"301","author":"Forrester","year":"2025","journal-title":"J Biol Chem"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.2217\/epi-2023-0373","article-title":"Histone deacetylase 6: at the interface of cancer and neurodegeneration","volume":"15","author":"Pu","year":"2023","journal-title":"Epigenomics"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1942607\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:53:31Z","timestamp":1787669611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1942607\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":94,"alternative-id":["10.3389\/fimmu.2026.1942607"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1942607","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1942607"}}